# Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis

> **NCT04314661** · PHASE1,PHASE2 · COMPLETED · sponsor: **PT. Prodia Stem Cell Indonesia** · enrollment: 31 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome
- **BIOLOGICAL:** Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome
- **BIOLOGICAL:** Non Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome
- **BIOLOGICAL:** Non Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome

## Key facts

- **NCT ID:** NCT04314661
- **Lead sponsor:** PT. Prodia Stem Cell Indonesia
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-03
- **Primary completion:** 2024-07-08
- **Final completion:** 2024-12-08
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04314661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04314661, "Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04314661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*